Who we are

Chairman:  Ralph Picklesralph-pickles

Also chairman of Polyphotonix Ltd; Director of Outward Grange
Academies Trust. Formerly President and Elected Officer of
Sensient Technologies Corporation (NYSE SXT) based in
Singapore and then the USA. Previously established the Quorn
business and grew to sales in six countries.

 


 

 

Vice Chairman and Founder:  Stephen CashStephen

Led the first ICI business unit MBO, establishing Cleveland
Chemicals Ltd. Then worked in new business development and
technology scouting for Thomas Swan & Co Ltd, establishing
world leading technologies in areas such as carbon nanotube
and carbon nanofibre manufacture. He is a non-executive
director of Nuformix Limited, Qflo Limited and Q Flo Energy
Limited.

 


 

 

Chief Executive Officer:  Keith RobsonSHE Keith Robson Photo

Over 25 years experience in micro and nanotechnology within
companies including 3M, Tioxide and ICI. before becoming
managing director of Ultramark Adhesive Products Limited,
a subsidiary of the US Corporation, Gerber Scientific.
He was formerly director of the Centre for Process Innovation’s Formulation Platform and CEO of AssuredNano Limited and Linear Diagnostics Limited.

 


 

 

Chief Technology Officer:  Prof Ian KinlochProfessor Ian Kinloch

Professor of Materials Science, University of Manchester.
Research focuses on polymer-nanocarbon composites,
electrodes and the bio-nano interface. Author of over 50 peer-
reviewed publications in the last 10 years.

 

 


 

 

Chief Scientific Officer:  Prof Peter Stockley

Professor of Biological Chemistry, The Astbury centre, University
of Leeds. A principal research interest is in the use of nucleic
aptamers as diagnostic, and therapeutic tools. Author of over 30
peer-reviewed publications in the last 5 years.

 


 

 

Clive Hutchinson

Finance Director:  Clive Hutchinson

Has over 20 years experience in the semi conductor industry in
senior management and board positions including Analog
Devices and IDT. More recently FD of two start ups and has
specialised in fund raising exit strategies.

 

 

 


 

US Development Director:  Dr Michael Jaffe

Currently a member of the research staff at the New Jersey
Innovation Institute. Formerly Research Professor of
Biomedical Engineering, Chemistry and Material Science
at the New Jersey Institute of Technology. Previously,
he was a Research Fellow at the Hoechst Celanese Corporation.